HAPPY NEWY. People music and performance
subhead-graphic

What is ERLEADA®?

ERLEADA® is a prescription medicine used to treat two types of prostate cancer:

Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone.

This is called metastatic castration-sensitive prostate cancer, or mCSPC.

OR

Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a medical or surgical treatment that lowers testosterone.

This is called non-metastatic castration-resistant prostate cancer, or nmCRPC.

subhead-graphic

How may ERLEADA® help you?

The short quiz below can help you find specific information about prostate cancer and ERLEADA®.

Please select the options that best describe your interest:

An illustration of a manface with smile

With ERLEADA®:

ciinical-results-icon

See the clinical results

shield-icon

Be informed about side effects

check-icon

Explore financial resources

Personalized Support. From People Who Care.

Once you and your doctor have decided that ERLEADA® is right for you, you have access to a free, personalized support program that connects you with a dedicated Care Navigator to help you get started with your treatment and stay on track.

Your personal Care Navigator is just a phone call away.

Request a Call
phone-icon

You can also call us at 844-NAV-1234 (844-628-1234),

Monday through Friday, 8:30 AM - 8:30 PM ET

janssen-compass-desktop
erleada-60mg_240mg logo

Patient Support from Janssen Compass™

Janssen Compass™ is limited to education for patients about their Janssen therapy, its administration, and/or their disease. It is intended to supplement a patient’s understanding of their therapy and is not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe this medication.